Drug intelligence / Profile preview

nystatin + neomycin + polymyxin B

Development stage
Phase 4
Lead developer
Laboratoire Innotech
Modality
Small Molecules
Administration
Vaginal, Topical
01

Overview

**nystatin + neomycin + polymyxin B** is a fixed-dose combination of two antibiotics (neomycin, an aminoglycoside; polymyxin B, a polypeptide) and one antifungal agent (nystatin, a polyene). It is used as a broad-spectrum empirical therapy for the local (vaginal) treatment of infectious vaginitis and related conditions, including those with mixed bacterial and fungal (often Candida albicans) etiologies. Neomycin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, while polymyxin B disrupts Gram-negative bacterial cell membranes via interaction with lipopolysaccharides, leading to cell death. Nystatin binds to ergosterol in fungal cell membranes, increasing their permeability and causing cell death. The combination covers most common fungal and bacterial pathogens implicated in vaginitis, including cases where the causative agent is not initially identified. Its rapid bactericidal and fungicidal actions make it effective for both aerobic and anaerobic bacteria, as well as for Candida species.

Brand names
PolygynaxNystoval
Other names
NNP combinationneomycin-polymyxin B-nystatinNystatin-Neomycin-Polymyxin B Combination
02

Targets

Bacterial RibosomeErgosterol

Beyond the preview

Go deeper on nystatin + neomycin + polymyxin B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nystatin + neomycin + polymyxin B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call